News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,004 Results
Type
Article (39159)
Company Profile (272)
Press Release (642573)
Section
Business (204457)
Career Advice (1990)
Deals (35455)
Drug Delivery (80)
Drug Development (80814)
Employer Resources (167)
FDA (16051)
Job Trends (14833)
News (345003)
Policy (32518)
Tag
Academia (2546)
Africa (714)
Alliances (49318)
Alzheimer's disease (1153)
Approvals (15970)
Arizona (174)
Artificial intelligence (69)
Asia (37017)
Australia (6032)
Bankruptcy (352)
Best Places to Work (11309)
Biosimilars (63)
Biotechnology (192)
C2C Services and Suppliers (79034)
California (1913)
Canada (941)
Cancer (497)
Career advice (1659)
Cell therapy (123)
China (151)
Clinical research (63350)
Collaboration (144)
Colorado (80)
Compensation (83)
Connecticut (75)
COVID-19 (2504)
Cystic fibrosis (73)
Data (319)
Diabetes (82)
Diagnostics (5995)
Drug pricing (66)
Earnings (83782)
Employer resources (142)
Europe (79136)
Events (108327)
Executive appointments (156)
FDA (16281)
Florida (268)
Funding (149)
Gene therapy (93)
GLP-1 (515)
Government (4305)
Healthcare (18633)
Hotbed/Location (482625)
Illinois (259)
Indiana (148)
Infectious disease (2533)
Inflammatory bowel disease (94)
Interviews (305)
IPO (16237)
Job creations (3653)
Job search strategy (1424)
Kansas (95)
Layoffs (398)
Legal (7865)
Lung cancer (111)
Manufacturing (88)
Maryland (400)
Massachusetts (1541)
Medical device (13055)
Medtech (13060)
Mergers & acquisitions (19094)
Metabolic disorders (251)
Michigan (124)
Minnesota (214)
Neuroscience (1302)
New Jersey (583)
New York (600)
NextGen Class of 2024 (6514)
Non-profit (4469)
North Carolina (590)
Northern California (832)
Obesity (148)
Ohio (108)
Opinion (175)
Patents (75)
Pennsylvania (587)
People (56172)
Phase I (19645)
Phase II (27905)
Phase III (20842)
Pipeline (113)
Postmarket research (2547)
Preclinical (8348)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (130)
Real estate (5928)
Recruiting (63)
Regulatory (21267)
Research institute (2311)
Resumes & cover letters (347)
South America (1088)
Southern California (777)
Startups (3611)
Texas (245)
United States (8658)
Vaccines (479)
Washington State (254)
Weight loss (129)
Date
Today (74)
Last 7 days (616)
Last 30 days (2433)
Last 365 days (37158)
2024 (26363)
2023 (40177)
2022 (51287)
2021 (55837)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32224)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26500)
2012 (28770)
2011 (29426)
2010 (27525)
682,004 Results for "akoya biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Akoya Biosciences Reports First Quarter 2024 Financial Results
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the first quarter ending March 31, 2024.
May 13, 2024
·
11 min read
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Genetown
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Akoya Biosciences, Inc., The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma patients, announced an exclusive agreement under which the parties will develop market opportunities for combining Akoya’s PhenoImager HT platform and NeraCare’s Immunoprint assay for patient stratification and therapy selection in early-stage melanoma patients.
May 9, 2024
·
5 min read
Business
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
Akoya Biosciences, Inc., The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler®-Fusion and the PhenoImager® HT platforms.
May 6, 2024
·
4 min read
Business
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2024 after the market close on May 13th, 2024.
April 22, 2024
·
1 min read
Genetown
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced that it has been named as a qualified contract research organization of Akoya Biosciences.
March 19, 2024
·
3 min read
Business
Akoya Biosciences Reports Second Quarter 2024 Financial Results
August 5, 2024
·
11 min read
Genetown
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
Akoya Biosciences, Inc., The Spatial Biology Company®, announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at the American Association for Cancer Research 2024 Annual Meeting in San Diego, April 5 to 10.
April 5, 2024
·
7 min read
Business
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ending December 31, 2023.
March 4, 2024
·
8 min read
Genetown
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it has entered into a license and distribution agreement with Thermo Fisher Scientific, Inc.
January 7, 2024
·
3 min read
1 of 68,201
Next